Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in November

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the recipient of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 27,600 shares, a decline of 16.6% from the October 31st total of 33,100 shares. Based on an average daily volume of 48,300 shares, the short-interest ratio is currently 0.6 days.

Ocean Biomedical Stock Down 9.8 %

OCEAW opened at $0.04 on Monday. Ocean Biomedical has a fifty-two week low of $0.02 and a fifty-two week high of $0.70. The company has a fifty day moving average of $0.04 and a 200 day moving average of $0.05.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.